[ad_1] Adela’s tissue-agnostic MRD test has been clinically validated to predict and surveil for recurrence in patients with head & neck cancer, regardless of HPV status The test identified recurrences in head & neck cancer […]
Trending Stories
Global AI Summit Calls for Global Action to Guarantee AI Innovation is for the “Good of Humanity”
[ad_1] RIYADH, Saudi Arabia, Sept. 14, 2024 /PRNewswire/ — The Global AI Summit (GAIN) in Riyadh concluded on a high, after the summit welcomed more than 30,000 delegates from across the globe over three days. The […]
RYBREVANT® (amivantamab-vmjw) plus chemotherapy show 49 percent overall response rate in metastatic colorectal cancer
[ad_1] Median duration of response reaches 7.4 months with combination treatment in patients with aggressive form of disease New results show potential of RYBREVANT® beyond lung cancer BARCELONA, Sept. 14, 2024 /PRNewswire/ — Johnson & Johnson (NYSE:JNJ) […]
Uncover the ZERO 40 Sequence GoPro Form
[ad_1] Infinix Faucets Porsche Dreamer Tales Featured Author: Uncover the ZERO 40 Sequence GoPro Form Swim with Giants: Revel in Whale Sharks Like By no means Earlier than with This Professional-Stage Vlog Smartphone! HONG KONG, […]
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
[ad_1] NANJING, China, Sept. 14, 2024 /PRNewswire/ — On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the […]
